Pericardial Bioprosthesis
- UID
- IMP/MD/2018/000133_b139746a26dbcd9ee5cf0f9ac7f51844_2b95924f43f7557791bc4265e884f96b
- Device class
- Class D
- Brand name
- MITRIS RESILIA Mitral Valve
- License holder
- Edwards Lifesciences (India) Private Limited,
- Approving authority
- CDSCO
- Product information
- The Magna Ease aortic bioprosthesis is intended for use in patients whose aortic valvular disease is sufficiently advanced to warrant replacement of their natural valve with a prosthetic one. It is also intended for use in patients with a previously implanted aortic valve prosthesis that is no longer functioning adequately and requires replacement. In the latter case, the previously implanted prosthesis is surgically excised and replaced by the replacement prosthesis. The bioprosthesis can be implanted in either the super-annular or intra-annular position
Pericardial Bioprosthesis is a medical device registered with India's Central Drugs Standard Control Organization (CDSCO) under UID IMP/MD/2018/000133_b139746a26dbcd9ee5cf0f9ac7f51844_2b95924f43f7557791bc4265e884f96b. This device is marketed under the brand name MITRIS RESILIA Mitral Valve. The license holder is Edwards Lifesciences (India) Private Limited,, and it is classified as Device Class Class D. The approving authority is CDSCO.
This page provides comprehensive regulatory information including complete registration details, license holder information, device classification, and related products. Pure Global AI offers free access to 71,807+ India medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.